ANALIZA, INC.

Basic Information

ANALIZA, INC.
408 GLEN PARK DR
BAY VILLAGE, OH, 44140

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Structural Signatures for Quality Control of Proteins

    Amount: $120,567.00

    DESCRIPTION (provided by applicant): Higher-order structural information for biomolecules is an important component of quality control activities for recombinant proteins. Unfortunately, detailed stru ...

    SBIR Phase I 2004 Department of Health and Human Services
  2. RAPID QUALITY CONTROL TECHNOLOGY FOR BIODEFENSE VACCINES

    Amount: $99,242.00

    DESCRIPTION (Provided by applicant): Due to the anticipated significant increase in the number of potential vaccines for CDC Category A agents in the near future, it is imperative that a rapid respons ...

    SBIR Phase I 2002 Department of Health and Human Services
  3. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  4. N/A

    Amount: $377,307.00

    N/A

    SBIR Phase II 2000 Department of Health and Human Services
  5. MICROHETEROGENEITY IN BIOPRODUCTS

    Amount: $749,995.00

    The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potenc ...

    SBIR Phase II 1998 Department of Health and Human Services
  6. NEW METHOD FOR MEASUREMENT OF CDT LEVEL IN SERUM

    Amount: $99,750.00

    DESCRIPTION: (Adapted from the applicant's abstract) The innovation described in this proposal is aimed at providing a new method for detection of carbohydrate-deficient transferrin (CDT) in human blo ...

    SBIR Phase I 1997 Department of Health and Human Services
  7. MICROHETEROGENEITY IN BIOPRODUCTS

    Amount: $99,938.00

    The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potenc ...

    SBIR Phase I 1997 Department of Health and Human Services
  8. NEW METHOD FOR QSAR FOR BIOPHARMACEUTICAL PRODUCTS

    Amount: $94,588.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  9. DEVELOPMENT OF HUMANE TATTOO SYSTEM OF SMALL RODENTS

    Amount: $349,688.00

    THE PHASE I PROJECT RESULTED IN THE DEVELOPMENT OF SEVERAL TATTOO PIGMENTS THAT WERE EFFECTIVE IN IDENTIFYING B6C3F1 BROWN MICE IN A 3-MONTH STUDY. THESE PIGMENTS DID NOT AFFECT GROWTH OR MORTALITY; H ...

    SBIR Phase II 1991 Department of Health and Human Services
  10. DEVELOPMENT OF A HUMANE TATTOO SYSTEM FOR VISUAL AND INSTRUMENTAL PERMANENT IDENTIFICATION OF SMALL RODENTS.

    Amount: $349,688.00

    THIS PHASE 1 PROJECT WILL RESULT IN DEVELOPMENT OF PIGMENTS, TATTOO EQUIPMENT AND PROCEDURES FOR VISUAL AND INSTRUMENTAL IDENTIFICATION OF DARK COLORED RODENTS. THE B6C3F1 BROWN MOUSE WILL BE USED AS ...

    SBIR Phase II 1989 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government